Bipolar disorder trials in Croatia

2 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

  Where

  Zagreb

  Age

  18 years to 65 years

  People

  274 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06951711
• Phase 3Taking people
  A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

  Where

  Grad Zagreb

  Age

  18 years to 65 years

  People

  450 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06929273 · EU 2024-520259-26-00